The report analyzed 667 drugs approved for sale by the US Food and Drug Administration since 1996. Approvals hit a low point in 2008 with just 19 new drugs joining the market. In 1997 and 2015, ...

It found that, of 107 responses, only 3% deemed that digital transformation would have no impact on the drug development timeline while ... efficiency in the drug discovery and development process ...

The Drug Discovery programme is Alzheimer's Society's innovative approach to dementia treatment development. The result of which means new, better treatments could be available in half the time of a ...

Drug discovery is changing ... of active preclinical combinations in under 24 months. The truncated timeline was enabled by an AI-powered approach that could cut the total time needed to get ...

By eliminating some of the guesswork from the process, AI promises to cut the cost and timeline. Standigm is one of the early pioneers to apply the power of AI technologies to drug discovery and ...